Dr Stauder is an Associate Professor of Radiation Oncology at MD Anderson Cancer Center in Houston, Texas. He is a member of the Morgan Welch Inflammatory Breast Cancer Research Program and Clinic. His research focus centers on the design and development of prospective clinical trials for evaluation of immunotherapy in combination with radiation especially in triple negative, inflammatory and (oligo) metastatic hormone positive breast cancer.

Dr Stauder is also interested in the development of novel radio sensitizers, new image guided radiotherapy techniques and functional imaging for the effective treatment of breast cancer and other solid tumors. Dr Stauder earned his undergraduate degree from The University of Chicago and earned his medical degree from University of Wisconsin School of Medicine and Public Health.

He then completed his clinical internship year at The University of Illinois-Chicago and a clinical residency in Radiation Oncology at Mayo Clinic, Rochester, MN.

Radiation therapy is the standard of care in many aspects of breast cancer treatment. In recent years, advances in treatment planning and delivery have enabled personalization of radiotherapy plans to maximize coverage while minimizing toxicity. Published evidence on dose fractionation and radiation fields have also established new standards of care compared to the previous decade.

Neoadjuvant strategies as well as new surgical standards in the management of the axilla, and improved Breast reconstruction techniques have presented a range of new adjuvant radiotherapy scenarios all which require a sound basis for treatment decision.

Dr Stauder brings with him a wealth of knowledge and experience as he shares on these in his lecture update. He will also speak on his experience with inflammatory breast cancers and share his thoughts on the future of accelerated partial breast irradiation and the application of proton beam therapy in breast cancer.